The Valley Desk

ArticleClinical lymphoma, myeloma & leukemiaPublished

Real-World Treatment Patterns and Outcomes in Patients With Lenalidomide-Refractory Multiple Myeloma With 1 to 3 Prior Lines: SEER-Medicare Database

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Clinical lymphoma, myeloma & leukemia
Published
Subject terms
Humans; Multiple Myeloma; Antineoplastic Combined Chemotherapy Protocols; Treatment Outcome; SEER Program; Drug Resistance, Neoplasm; Aged; Aged, 80 and over; Medicare; United States; Female; Male
PubMed ID
39966019
Added to directory
Source checked

Report a correction or request removal